The stock market is buzzing with activity this morning, with Intel Corporation’s (INTC) shares taking center stage. The semiconductor giant saw a sharp rise in pre-market trading, fueled by the announcement of a strategic collaboration with Amazon Web Services (AWS). This partnership aims to accelerate the development of US-based chip manufacturing, a move that has investors excited. Intel shares jumped a notable 6.9% to $22.36 in the pre-market session.
But Intel isn’t the only stock making headlines. Let’s take a closer look at some other prominent pre-market movers:
Gainers:
*
Galmed Pharmaceuticals Ltd (GLMD):
This pharmaceutical company saw an impressive 73.1% surge to $6.70 in pre-market trading, rebounding after a 6% decline on Monday. The reason for this dramatic turnaround remains unclear but likely points to positive news or investor sentiment.*
Smith Micro Software, Inc (SMSI):
After a Monday dip of around 9%, Smith Micro Software bounced back with a remarkable 62.4% gain, reaching $0.8499 in pre-market.*
Wheeler Real Estate Investment Trust, Inc (WHLR):
Following a 35% surge on Monday, Wheeler Real Estate continued its upward trajectory, gaining another 36.7% to $10.05 in pre-market trading.*
Allarity Therapeutics, Inc (ALLR):
Allarity Therapeutics climbed 21.3% to $4.10 in pre-market, indicating potential positive developments within the company.*
Adagio Medical Holdings, Inc (ADGM):
Adagio Medical saw a healthy 16.5% increase to $4.81 in pre-market trading.*
Healthy Choice Wellness Corp (HCWC):
After a steep decline of 48% on Monday, Healthy Choice Wellness rebounded with a 14.5% rise to $6.00 in pre-market.*
Mynaric AG (MYNA):
Mynaric AG continued its positive momentum, gaining 13.9% to $0.90 in pre-market after a 13% gain on Monday.*
SciSparc Ltd (SPRC):
SciSparc’s shares rose 12% to $0.3490 in pre-market trading. This increase may be linked to the announcement of a new international patent application for a pioneering ibogaine combination therapy developed in collaboration with Clearmind Medicine.*
Avinger, Inc (AVGR):
Avinger gained 10.5% to $1.47 in pre-market trading. The company’s announcement of a newly issued U.S. patent for treating occlusive coronary artery disease likely contributed to this surge.Losers:
*
Netcapital Inc (NCPL):
Netcapital’s shares took a significant hit, falling 33% to $1.93 in pre-market trading after the company reported its first-quarter earnings results.*
NKGen Biotech, Inc (NKGN):
NKGen Biotech’s shares dipped 19.4% to $0.60 in pre-market, following a 4% decline on Monday. This drop may be attributed to the recent release of early interim data from a Phase 1 cohort and the dosing of the first Phase 2 patient in a clinical trial.*
Dermata Therapeutics, Inc (DRMA):
Dermata Therapeutics fell 14.2% to $1.99 in pre-market trading. The company’s announcement of a $3.5 million private placement likely contributed to this decline.*
Golden Heaven Group Holdings Ltd (GDHG):
Following a 5% gain on Monday, Golden Heaven’s shares fell 12.7% to $0.0916 in pre-market trading.*
Bone Biologics Corporation (BBLG):
After a remarkable 136% jump on Monday, Bone Biologics saw a significant 12.7% decline to $1.65 in pre-market.*
CN Energy Group. Inc (CNEY):
CN Energy fell 11.6% to $0.42 in pre-market trading after a 6% gain on Monday. The company recently received a noncompliance notice from Nasdaq.*
Ocean Power Technologies, Inc (OPTT):
Following the release of its quarterly results, Ocean Power Technologies shares declined 9.6% to $0.2259 in pre-market.*
Aptevo Therapeutics Inc (APVO):
Aptevo Therapeutics fell 9.1% to $0.30 in pre-market trading. The company announced a $3.0 million offering, likely contributing to the decline.*
Tenon Medical, Inc (TNON):
Tenon Medical saw an 8.7% drop to $7.04 in pre-market trading.*
ZyVersa Therapeutics, Inc (ZVSA):
After a 9% gain on Monday, ZyVersa Therapeutics declined 7.2% to $2.21 in pre-market trading.Keep in mind that pre-market trading often reflects anticipation and can be volatile. It’s always crucial to consult with a financial advisor before making any investment decisions.
